Laciniatoside V | CAS#120416-05-9 | metabolite

MedKoo Cat#: 598203 | Name: Laciniatoside V

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Laciniatoside V is a metabolite.

Chemical Structure

Laciniatoside V

CAS#120416-05-9

Theoretical Analysis

MedKoo Cat#: 598203

Name: Laciniatoside V

CAS#: 120416-05-9

Chemical Formula: C27H38O14

Exact Mass: 586.2262

Molecular Weight: 586.58

Elemental Analysis: C, 55.29; H, 6.53; O, 38.18

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Laciniatoside V;

IUPAC/Chemical Name

methyl (1R,4aS,6S,7R,7aS)-1-hydroxy-6-(((2S,3R,4S)-4-(2-hydroxyethyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-vinyl-3,4-dihydro-2H-pyran-5-carbonyl)oxy)-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate

InChi Key

MXXRZVWQIBOVFZ-CQWPOWKPSA-N

InChi Code

InChI=1S/C27H38O14/c1-4-12-13(5-6-28)15(10-38-26(12)41-27-22(32)21(31)20(30)18(8-29)40-27)24(34)39-17-7-14-16(23(33)36-3)9-37-25(35)19(14)11(17)2/h4,9-14,17-22,25-32,35H,1,5-8H2,2-3H3/t11-,12+,13-,14+,17-,18+,19+,20+,21-,22+,25+,26-,27-/m0/s1

SMILES Code

O[C@H]1[C@H]([C@@H](C)[C@@H](OC(C2=CO[C@@H](O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)[C@H](C=C)[C@@H]2CCO)=O)C4)[C@H]4C(C(OC)=O)=CO1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 586.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Soe CZ, Pakchung AA, Codd R. Dinuclear [(V(V)O(putrebactin))2(μ-OCH3)2] formed in solution as established from LC-MS measurements using 50V-enriched V2O5. Inorg Chem. 2014 Jun 2;53(11):5852-61. doi: 10.1021/ic500787v. Epub 2014 May 16. PubMed PMID: 24834956. 2: Chen T, Li TQ, Yang JY. Damage suffered by swamp morning glory (Ipomoea aquatica Forsk) exposed to vanadium (V). Environ Toxicol Chem. 2016 Mar;35(3):695-701. doi: 10.1002/etc.3226. Epub 2016 Feb 3. PubMed PMID: 26329124. 3: Ciprandi G, Comite P, Mussap M, De Amici M, Quaglini S, Barocci F, Marseglia GL, Scala E. Profiles of Birch Sensitization (Bet v 1, Bet v 2, and Bet v 4) and Oral Allergy Syndrome Across Italy. J Investig Allergol Clin Immunol. 2016;26(4):244-8. doi: 10.18176/jiaci.0041. PubMed PMID: 27470643. 4: Chakrabarti S, Wu X, Yang Z, Wu L, Yong SL, Zhang C, Hu K, Wang QK, Chen Q. MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):392-401. doi: 10.1161/CIRCEP.111.000206. Epub 2013 Feb 18. PubMed PMID: 23420830; PubMed Central PMCID: PMC3633223. 5: Husslik F, Hanschmann KM, Krämer A, Seutter von Loetzen C, Schweimer K, Bellinghausen I, Treudler R, Simon JC, Vogel L, Völker E, Randow S, Reuter A, Rösch P, Vieths S, Holzhauser T, Schiller D. Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations. PLoS One. 2015 Jul 17;10(7):e0132956. doi: 10.1371/journal.pone.0132956. eCollection 2015. PubMed PMID: 26186356; PubMed Central PMCID: PMC4506129. 6: Zhang F, Mi Y, Qi JL, Li JW, Si M, Guan BC, Du XN, An HL, Zhang HL. Modulation of K(v)7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58. Br J Pharmacol. 2013 Feb;168(4):1030-42. doi: 10.1111/j.1476-5381.2012.02232.x. PubMed PMID: 23013484; PubMed Central PMCID: PMC3631389. 7: Meng X, Xu Y, Zhao M, Wang F, Ma Y, Jin Y, Liu Y, Song Y, Zhang J. The Functional Property Changes of Muscular Na(v)1.4 and Cardiac Na(v)1.5 Induced by Scorpion Toxin BmK AGP-SYPU1 Mutants Y42F and Y5F. Biochemistry. 2015 May 19;54(19):2988-96. PubMed PMID: 25919575. 8: Vetter I, Mozar CA, Durek T, Wingerd JS, Alewood PF, Christie MJ, Lewis RJ. Characterisation of Na(v) types endogenously expressed in human SH-SY5Y neuroblastoma cells. Biochem Pharmacol. 2012 Jun 1;83(11):1562-71. doi: 10.1016/j.bcp.2012.02.022. Epub 2012 Mar 3. PubMed PMID: 22410003. 9: Kim DH, Lee SJ, Hahn SJ, Choi JS. Trifluoperazine blocks the human cardiac sodium channel, Na(v)1.5, independent of calmodulin. Biochem Biophys Res Commun. 2016 Oct 21;479(3):584-589. doi: 10.1016/j.bbrc.2016.09.115. Epub 2016 Sep 23. PubMed PMID: 27666479. 10: Knapp O, Nevin ST, Yasuda T, Lawrence N, Lewis RJ, Adams DJ. Biophysical properties of Na(v) 1.8/Na(v) 1.2 chimeras and inhibition by µO-conotoxin MrVIB. Br J Pharmacol. 2012 Aug;166(7):2148-60. doi: 10.1111/j.1476-5381.2012.01955.x. PubMed PMID: 22452751; PubMed Central PMCID: PMC3402778. 11: Landoulsi Z, Miceli F, Palmese A, Amoresano A, Marino G, El Ayeb M, Taglialatela M, Benkhalifa R. Subtype-selective activation of K(v)7 channels by AaTXKβ₂₋₆₄, a novel toxin variant from the Androctonus australis scorpion venom. Mol Pharmacol. 2013 Nov;84(5):763-73. doi: 10.1124/mol.113.088971. Epub 2013 Sep 9. PubMed PMID: 24019223. 12: Zhang X, An H, Li J, Zhang Y, Liu Y, Jia Z, Zhang W, Chu L, Zhang H. Selective activation of vascular K(v) 7.4/K(v) 7.5 K(+) channels by fasudil contributes to its vasorelaxant effect. Br J Pharmacol. 2016 Dec;173(24):3480-3491. doi: 10.1111/bph.13639. Epub 2016 Nov 1. PubMed PMID: 27677924; PubMed Central PMCID: PMC5120158. 13: Vandael DH, Zuccotti A, Striessnig J, Carbone E. Ca(V)1.3-driven SK channel activation regulates pacemaking and spike frequency adaptation in mouse chromaffin cells. J Neurosci. 2012 Nov 14;32(46):16345-59. doi: 10.1523/JNEUROSCI.3715-12.2012. PubMed PMID: 23152617. 14: Nikouee A, Janbein M, Grissmer S. Verapamil- and state-dependent effect of 2-aminoethylmethanethiosulphonate (MTSEA) on hK(v)1.3 channels. Br J Pharmacol. 2012 Nov;167(6):1378-88. doi: 10.1111/j.1476-5381.2012.02092.x. PubMed PMID: 22748056; PubMed Central PMCID: PMC3505002. 15: Inderbitzin P, Davis RM, Bostock RM, Subbarao KV. Identification and Differentiation of Verticillium Species and V. longisporum Lineages by Simplex and Multiplex PCR Assays. PLoS One. 2013 Jun 18;8(6):e65990. doi: 10.1371/journal.pone.0065990. Print 2013. PubMed PMID: 23823707; PubMed Central PMCID: PMC3688845. 16: Jankunas J, Sneha M, Zare RN, Bouakline F, Althorpe SC. Disagreement between theory and experiment grows with increasing rotational excitation of HD(v', j') product for the H + D2 reaction. J Chem Phys. 2013 Mar 7;138(9):094310. doi: 10.1063/1.4793557. PubMed PMID: 23485297. 17: Pakchung AA, Soe CZ, Lifa T, Codd R. Complexes formed in solution between vanadium(IV)/(V) and the cyclic dihydroxamic acid putrebactin or linear suberodihydroxamic acid. Inorg Chem. 2011 Jul 4;50(13):5978-89. doi: 10.1021/ic1025119. Epub 2011 May 31. PubMed PMID: 21627146; PubMed Central PMCID: PMC3124108. 18: Yokoyama T, Minami K, Sudo Y, Horishita T, Ogata J, Yanagita T, Uezono Y. Effects of sevoflurane on voltage-gated sodium channel Na(v)1.8, Na(v)1.7, and Na(v)1.4 expressed in Xenopus oocytes. J Anesth. 2011 Aug;25(4):609-13. doi: 10.1007/s00540-011-1167-7. Epub 2011 Jun 8. PubMed PMID: 21656091. 19: Kim DY, Gersbacher MT, Inquimbert P, Kovacs DM. Reduced sodium channel Na(v)1.1 levels in BACE1-null mice. J Biol Chem. 2011 Mar 11;286(10):8106-16. doi: 10.1074/jbc.M110.134692. Epub 2010 Dec 29. PubMed PMID: 21190943; PubMed Central PMCID: PMC3048697. 20: Tegla CA, Cudrici C, Rozycka M, Soloviova K, Ito T, Singh AK, Khan A, Azimzadeh P, Andrian-Albescu M, Khan A, Niculescu F, Rus V, Judge SI, Rus H. C5b-9-activated, K(v)1.3 channels mediate oligodendrocyte cell cycle activation and dedifferentiation. Exp Mol Pathol. 2011 Aug;91(1):335-45. doi: 10.1016/j.yexmp.2011.04.006. Epub 2011 Apr 22. PubMed PMID: 21540025; PubMed Central PMCID: PMC3139709.